{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:58:22Z","timestamp":1785484702801,"version":"3.56.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.lrr.2026.100580","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:20:25Z","timestamp":1773458425000},"page":"100580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["T-cell receptor anti-CMV CDR3s from bone marrow samples are associated with a worse overall survival for recurrent acute myeloid leukemia"],"prefix":"10.1016","volume":"25","author":[{"given":"Srijit","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Aboujaoude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vayda R.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabitha R.","family":"Hudock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpan","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1664-0996","authenticated-orcid":false,"given":"George","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lrr.2026.100580_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061405","article-title":"High-risk acute myeloid leukemia: a pediatric prospective","volume":"10","author":"Cacace","year":"2022","journal-title":"Biomedicines"},{"issue":"20","key":"10.1016\/j.lrr.2026.100580_bib0002","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2015-11-679639","article-title":"Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis","volume":"127","author":"Teira","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.lrr.2026.100580_bib0003","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.lrr.2026.100580_bib0004","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","article-title":"Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients","volume":"118","author":"Elmaagacli","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2026.100580_bib0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-1-0716-2712-9_13","article-title":"Epitope-specific T cell receptor data and tools in the immune epitope database","volume":"2574","author":"Chronister","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"9","key":"10.1016\/j.lrr.2026.100580_bib0006","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41592-022-01578-0","article-title":"VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2","volume":"19","author":"Goncharov","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.lrr.2026.100580_bib0007","doi-asserted-by":"crossref","DOI":"10.1089\/vim.2019.0156","article-title":"Antiviral T cell receptor complementarity determining region-3 sequences are associated with a worse cancer outcome: a pancancer analysis","author":"Zaman","year":"2020","journal-title":"Viral. Immunol."},{"issue":"13","key":"10.1016\/j.lrr.2026.100580_bib0008","doi-asserted-by":"crossref","first-page":"12047","DOI":"10.1007\/s00432-023-05059-5","article-title":"Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma","volume":"149","author":"Kacsoh","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.lrr.2026.100580_bib0009","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41435-023-00201-2","article-title":"Tumor resident, TRA anti-viral CDR3 chemical sequence motifs are associated with a better breast cancer outcome","volume":"24","author":"Diaz","year":"2023","journal-title":"Genes. Immun."},{"key":"10.1016\/j.lrr.2026.100580_bib0010","first-page":"23","article-title":"Detection of productively rearranged TcR-alpha V-J sequences in TCGA exome files: implications for tumor immunoscoring and recovery of antitumor T-cells","volume":"15","author":"Gill","year":"2016","journal-title":"Cancer Inf."},{"issue":"3","key":"10.1016\/j.lrr.2026.100580_bib0011","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/21645515.2016.1246095","article-title":"Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: evidence for high level B-cell infiltrates in breast cancer","volume":"13","author":"Tong","year":"2017","journal-title":"Hum. Vaccin. ImmunOther"},{"issue":"3","key":"10.1016\/j.lrr.2026.100580_bib0012","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11060-018-03001-1","article-title":"Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade","volume":"140","author":"Chobrutskiy","year":"2018","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.lrr.2026.100580_bib0013","first-page":"1","article-title":"High GLP1R gene copy numbers associated with microsatellite instability for multiple cancers and with better survival probabilities for glioblastoma","author":"Thomas","year":"2025","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.lrr.2026.100580_bib0014","doi-asserted-by":"crossref","first-page":"439","DOI":"10.21873\/cgp.20462","article-title":"Worse Wilms' Tumor outcomes associated with chemical complementarity for multiple T-cell receptor CDR3-CMV epitope pairs","volume":"21","author":"Rigby","year":"2024","journal-title":"Cancer Genom. Proteom."},{"issue":"1","key":"10.1016\/j.lrr.2026.100580_bib0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/bloodadvances.2021005509","article-title":"Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG","volume":"6","author":"Turki","year":"2022","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.lrr.2026.100580_bib0016","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3892\/mco.2015.692","article-title":"Valganciclovir and bevacizumab for recurrent glioblastoma: a single-institution experience","volume":"4","author":"Peng","year":"2016","journal-title":"Mol. Clin. Oncol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048926000208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:11:32Z","timestamp":1785481892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048926000208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":16,"alternative-id":["S2213048926000208"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100580","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-cell receptor anti-CMV CDR3s from bone marrow samples are associated with a worse overall survival for recurrent acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2026.100580","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100580"}}